RATIONALE: Virus-induced wheezing episodes in infancy often precede the development of asthma. Whether infections with specific viral pathogens confer differential future asthma risk is incompletely understood. OBJECTIVES: To define the relationship between specific viral illnesses and early childhood asthma development. METHODS: A total of 259 children were followed prospectively from birth to 6 years of age. The etiology and timing of specific viral wheezing respiratory illnesses during early childhood were assessed using nasal lavage, culture, and multiplex reverse transcriptase-polymerase chain reaction. The relationships of these virus-specific wheezing illnesses and other risk factors to the development of asthma were analyzed. MEASUREMENTS AND MAIN RESULTS: Viral etiologies were identified in 90% of wheezing illnesses. From birth to age 3 years, wheezing with respiratory syncytial virus (RSV) (odds ratio [OR], 2.6), rhinovirus (RV) (OR, 9.8), or both RV and RSV (OR , 10) was associated with increased asthma risk at age 6 years. In Year 1, both RV wheezing (OR, 2.8) and aeroallergen sensitization (OR, 3.6) independently increased asthma risk at age 6 years. By age 3 years, wheezing with RV (OR, 25.6) was more strongly associated with asthma at age 6 years than aeroallergen sensitization (OR, 3.4). Nearly 90% (26 of 30) of children who wheezed with RV in Year 3 had asthma at 6 years of age. CONCLUSIONS: Among outpatient viral wheezing illnesses in infancy and early childhood, those caused by RV infections are the most significant predictors of the subsequent development of asthma at age 6 years in a high-risk birth cohort.
RATIONALE: Virus-induced wheezing episodes in infancy often precede the development of asthma. Whether infections with specific viral pathogens confer differential future asthma risk is incompletely understood. OBJECTIVES: To define the relationship between specific viral illnesses and early childhood asthma development. METHODS: A total of 259 children were followed prospectively from birth to 6 years of age. The etiology and timing of specific viral wheezing respiratory illnesses during early childhood were assessed using nasal lavage, culture, and multiplex reverse transcriptase-polymerase chain reaction. The relationships of these virus-specific wheezing illnesses and other risk factors to the development of asthma were analyzed. MEASUREMENTS AND MAIN RESULTS: Viral etiologies were identified in 90% of wheezing illnesses. From birth to age 3 years, wheezing with respiratory syncytial virus (RSV) (odds ratio [OR], 2.6), rhinovirus (RV) (OR, 9.8), or both RV and RSV (OR , 10) was associated with increased asthma risk at age 6 years. In Year 1, both RV wheezing (OR, 2.8) and aeroallergen sensitization (OR, 3.6) independently increased asthma risk at age 6 years. By age 3 years, wheezing with RV (OR, 25.6) was more strongly associated with asthma at age 6 years than aeroallergen sensitization (OR, 3.4). Nearly 90% (26 of 30) of children who wheezed with RV in Year 3 had asthma at 6 years of age. CONCLUSIONS: Among outpatient viral wheezing illnesses in infancy and early childhood, those caused by RV infections are the most significant predictors of the subsequent development of asthma at age 6 years in a high-risk birth cohort.
Authors: James E Gern; Matthew S Martin; Kelly A Anklam; Kunling Shen; Kathy A Roberg; Kirstin T Carlson-Dakes; Kiva Adler; Stephanie Gilbertson-White; Rebekah Hamilton; Peter A Shult; Carol J Kirk; Douglas F Da Silva; Sarah A Sund; Michael R Kosorok; Robert F Lemanske Journal: Pediatr Allergy Immunol Date: 2002-12 Impact factor: 6.377
Authors: Christopher C Copenhaver; James E Gern; Zhanhai Li; Peter A Shult; Louis A Rosenthal; Lance D Mikus; Carol J Kirk; Kathy A Roberg; Elizabeth L Anderson; Christopher J Tisler; Douglas F DaSilva; Heidi J Hiemke; Kevin Gentile; Ronald E Gangnon; Robert F Lemanske Journal: Am J Respir Crit Care Med Date: 2004-04-15 Impact factor: 21.405
Authors: William A Neaville; Christopher Tisler; Abhik Bhattacharya; Kelly Anklam; Stephanie Gilbertson-White; Rebekah Hamilton; Kiva Adler; Douglas F Dasilva; Kathy A Roberg; Kirstin T Carlson-Dakes; Elizabeth Anderson; Debbie Yoshihara; Ronald Gangnon; Lance D Mikus; Louis A Rosenthal; James E Gern; Robert F Lemanske Journal: J Allergy Clin Immunol Date: 2003-10 Impact factor: 10.793
Authors: C S Devulapalli; K C L Carlsen; G Håland; M C Munthe-Kaas; M Pettersen; P Mowinckel; K-H Carlsen Journal: Thorax Date: 2007-07-05 Impact factor: 9.139
Authors: Robert C Strunk; Stanley J Szefler; Brenda R Phillips; Robert S Zeiger; Vernon M Chinchilli; Gary Larsen; Kevin Hodgdon; Wayne Morgan; Christine A Sorkness; Robert F Lemanske Journal: J Allergy Clin Immunol Date: 2003-11 Impact factor: 10.793
Authors: Anne Kotaniemi-Syrjänen; Raija Vainionpää; Tiina M Reijonen; Matti Waris; Kaj Korhonen; Matti Korppi Journal: J Allergy Clin Immunol Date: 2003-01 Impact factor: 10.793
Authors: Amy S Feldman; Yuan He; Martin L Moore; Marc B Hershenson; Tina V Hartert Journal: Am J Respir Crit Care Med Date: 2015-01-01 Impact factor: 21.405
Authors: Daniel Simancas-Racines; Juan Va Franco; Claudia V Guerra; Maria L Felix; Ricardo Hidalgo; Maria José Martinez-Zapata Journal: Cochrane Database Syst Rev Date: 2017-05-18
Authors: Ana M Mora; Jane A Hoppin; Leonel Córdoba; Juan C Cano; Manuel Soto-Martínez; Brenda Eskenazi; Christian H Lindh; Berna van Wendel de Joode Journal: Int J Hyg Environ Health Date: 2020-02-15 Impact factor: 5.840
Authors: Carlos E Rodríguez-Martínez; Jose A Castro-Rodriguez; Gustavo Nino; Fabio Midulla Journal: Paediatr Respir Rev Date: 2019-04-12 Impact factor: 2.726
Authors: Christopher D Codispoti; Grace K LeMasters; Linda Levin; Tiina Reponen; Patrick H Ryan; Jocelyn M Biagini Myers; Manuel Villareal; Jeff Burkle; Sherry Evans; James E Lockey; Gurjit K Khurana Hershey; David I Bernstein Journal: Ann Allergy Asthma Immunol Date: 2014-12-10 Impact factor: 6.347